Imaging reward circuitry to guide precision ketamine treatment in treatment-resistant depression

Dr. Mark Kvarta (NIMH) presents "Imaging reward circuitry to guide precision ketamine treatment in treatment-resistant depression."

Dr. Mark Kvarta is Medical Director and Director of Molecular and Cellular Biomarkers Research in the Experimental Therapeutics and Pathophysiology Branch at the National Institute of Mental Health (NIMH). His research examines how stress shapes the neurobiology of depression, linking neuroimaging, neuroendocrine, and genetic measures to clinical outcomes. He earned his PhD in neuroscience and his MD at the University of Maryland and completed his psychiatry residency in the University of Maryland/Sheppard Pratt research track.

Part of the PRAXIS Fall 2026 Speaker Series. This talk will not be recorded.